Top News
FEATURED
ASCO GU 2019 Symposium
Our complete coverage of the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco, CA.
Immunotherapy in Glioblastoma: Peaks and Pits
New studies in glioblastoma highlight how PD-1 inhibitors could simultaneously prompt an immune response and steer the selection of tumor clones that evade immune recognition.
Fact Sheet: Liquid Biopsies in Cancer
This fact sheet describes liquid biopsies and their uses in oncology.
Radical Prostatectomy vs Watchful Waiting
At 23 years of follow-up, the cumulative incidence of death was higher among patients in the watchful waiting group compared with those in the radical prostatectomy group.
Predictions in Medicine 2019: What's Ahead
A new partner in the fight to cure cancer. A once-unlikely source for combatting clinician burnout. These are some of the advances we and other experts predict will affect oncologists and their patients in 2019 and beyond. Take a look inside our crystal ball.
Ask the Experts: NSCLC
Cancer Therapy Advisor asked 2 experts to weigh in on recommended treatment modalities for patients with non-small cell lung cancer.
Ask the Experts: STS Clinical Insights
Cancer Therapy Advisor asked 2 experts to weigh in on the latest clinical insights into soft tissue sarcoma.
Ask the Experts: Waldenström Macroglobulinemia
Cancer Therapy Advisor asked 3 experts to weigh in on recommended treatment modalities for patients with Waldenström macroglobulinemia.
Looking for a Job?
Access our job board to view over 1,200 job openings throughout the US.
Treatment Regimens
A full listing of cancer treatment and drug information is available to access.
Latest Features
Immunotherapy in Glioblastoma: Peaks and Pits
New studies in glioblastoma highlight how PD-1 inhibitors could simultaneously prompt an immune response and steer the selection of tumor clones that evade immune recognition.
Radical Prostatectomy Compared With Watchful Waiting in Localized Prostate Cancer
At 23 years of follow-up, the cumulative incidence of death was higher among patients in the watchful waiting group compared with those in the radical prostatectomy group.
Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing
"People have shown that the variant-identification quality of WGS is superior to WES," said Dr Gerstein.
Immune Signature for Renal Cell Papillary Carcinoma Predicts Outcome
Researchers identified 15 genes that they said independently predict the survival outcome of patients with kidney renal papillary cell carcinoma.
Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves
Patient-reported outcomes, or PROs, are going to play a larger role in FDA cancer drug approvals, according to an expert in the field.
Editorial Advisory Board
E. David Crawford, MD
Jeffrey M. Farma, MD
Digital Issue
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Prostate Cancer | Regimens | Drugs |
| Rare Cancers | Regimens | |
| Renal Cell Carcinoma | Regimens | Drugs |
| Skin Cancer | Regimens | Drugs |
| Urologic Cancers | Regimens | Drugs |
Cancer Therapy Advisor Articles
- A Ketogenic Diet as an Adjunct to Cancer Treatment
- Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves
- Blinatumomab-Ponatinib Salvage Therapy in B-Cell Acute Lymphoblastic Leukemia: Case Report of Benefit
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma
- Nivolumab-Ipilimumab Survival Benefit in Advanced RCC Confirmed
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Adding Chemotherapy to Radiation Post-Radical Cystectomy Improves Survival in Urothelial Carcinoma
- Radiation, Chemotherapy Not Beneficial in Localized Upper Tract Urothelial Carcinoma
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer